Hypothesis versus association: The optimal hemoglobin target debate

American Journal of Kidney Diseases

Volumn 46, Issue 5, 2005, Pages 970-973

  Strippoli, Giovanni F M ^a   Craig, Jonathan C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DIALYSIS; DRUG EFFICACY; EDITORIAL; HEALTH CARE COST; HEART LEFT VENTRICLE MASS; HUMAN; KIDNEY GRAFT REJECTION; MEDICAL LITERATURE; MEDICAL RESEARCH; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SAMPLING; TREATMENT OUTCOME;

ANEMIA; BIAS (EPIDEMIOLOGY); BIOLOGICAL MARKERS; CHRONIC DISEASE; EPOETIN ALFA; GOALS; HEMOGLOBINS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; RANDOMIZED CONTROLLED TRIALS; REFERENCE VALUES; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 27144461980     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.09.009     Document Type: Editorial

References (19)

1. A. Levin, O. Djurdjev, C. Thompson Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD Am J Kidney Dis 46 2005 799 811
2. S. Roger, L.P. McMahon, A. Clarkson Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4) Results of a randomized clinical trial J Am Soc Nephrol 15 2004 148 156
3. P.S. Parfrey, R.N. Foley, B.H. Wittreich, D.J. Sullivan, M.J. Zagari, D. Frei Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease J Am Soc Nephrol 16 2005 2180 2189
4. T.B. Drüeke, N. Clyne, K.U. Eckhardt, F. Locatelli, I.C. MacDougall, D. Tsakaris Characteristics of chronic kidney disease patients enrolled in the Cardiovascular Risk Reduction by Early Anemia Treatment with Epoetin Beta (CREATE) study J Am Soc Nephrol 13 2002 520A (abstr SUPO0257)
5. R. Steinbrook Registration of clinical trials Voluntary or mandatory? N Engl J Med 351 2004 1820 1822
6. D. Moher, K.F. Schulz, D.G. Altman The CONSORT statement Revised recommendations for improving the quality of reports of parallel-group randomized trials Lancet 357 2000 1191 1194
7. D.A. Braunholtz, S.J. Edwards, R.J. Lilford Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect" J Clin Epidemiol 54 2001 217 224
8. A.J. Collins, J.Z. Ma, A. Xia, J. Ebben Trends in anemia treatment with erythropoietin usage and patient outcomes Am J Kidney Dis 32 suppl 4 1998 S133 S141
9. H.C. Bucher, G.H. Guyatt, D.J. Cook Evidence-Based Working Group Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate endpoints JAMA 282 1999 771 778
10. B.M. Psaty, N.S. Weiss, C.D. Furberg Surrogate endpoints, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease JAMA 282 1999 786 790
11. R. Temple Are surrogate markers adequate to assess cardiovascular disease drugs? JAMA 282 1999 790 795
12. D.M. Churchill, K.E. Thorpe, E.F. Vonesh, P.R. Keshaviah Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group J Am Soc Nephrol 8 1997 965 971
13. A. Besarab, W.K. Bolton, J.K. Browne The effects of normal, as compared with low, hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin N Engl J Med 339 1998 584 590
14. L.P. McMahon, S.D. Roger, A. Levin SLIMHEART Investigators Group Development, prevention and potential reversal of left ventricular hypertrophy in chronic kidney disease J Am Soc Nephrol 15 2004 1640 1647
15. G.F. Strippoli, J.C. Craig, C. Manno, F.P. Schena Hemoglobin targets for the anemia of chronic kidney disease A meta-analysis of randomized, controlled trials J Am Soc Nephrol 15 2004 3154 3165
16. B. Leyland-Jones BEST Investigators and Study Group Breast cancer trial with erythropoietin terminated unexpectedly Lancet Oncol 4 2003 459 460
17. S.P. McDonald, J.C. Craig Australian and New Zealand Paediatric Nephrology Association. Long-term survival of children with end-stage renal disease N Engl J Med 350 2004 2654 2662
18. US Renal Data System. Available at: www.usrds.org Accessed: August 15, 2005.
19. Australia and New Zealand Dialysis and Transplant Registry: Available at: www.anzdata.org.au. Accessed: August 15, 2005